Description: Creating an Affordable, Sustainable and Personalized Medicine for Society by using human placenta proteins for cell culture applications.
THT Biomaterials GmbH aims to overcome major methodological issues at the bottom of today’s drug development, tissue engineering and regenerative medicine research practices leading to false positive or negative results. A new visionary platform technology is under development that will speed up research as it makes its results more realistic by replacing animal components with human components.
Animal material free cell culture (3R)
Better quality because of the same species